- Home
- BTAI vs TCBS Comparison
BTAI vs TCBS Comparison
Compare BTAI & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTAI | TCBS |
|---|---|---|
| Founded | 2017 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 47.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTAI | TCBS |
|---|---|---|
| Price | $1.80 | $16.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $26.67 | N/A |
| AVG Volume (30 Days) | ★ 644.4K | 2.3K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | $752,000.00 | ★ $15,268,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $265.60 | N/A |
| P/E Ratio | ★ N/A | $18.74 |
| Revenue Growth | N/A | ★ 54.88 |
| 52 Week Low | $1.17 | $15.01 |
| 52 Week High | $8.08 | $20.00 |
Technical Indicators
Market Signals| Indicator | BTAI | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 43.00 |
| Support Level | $1.85 | $16.50 |
| Resistance Level | $2.08 | $16.80 |
| Average True Range (ATR) | 0.15 | 0.57 |
| MACD | 0.00 | -0.16 |
| Stochastic Oscillator | 38.57 | 0.27 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.